Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Apollo to separate out...

    Apollo to separate out its pharmacy business, seeks shareholders nod

    Farhat NasimWritten by Farhat Nasim Published On 18 Sept 2019 12:07 PM  |  Updated On 16 Aug 2021 7:28 AM

    New Delhi: Based on the directions of National Company Law Tribunal (NCLT), Apollo Hospitals Enterprise Ltd (AHEL) has proposed to hive off its pharmacy business. Apollo Hospitals has convened a shareholders meeting in this regard on October 21 2019, to deliberate and approve the Scheme of the arrangement between Apollo Hospitals and Apollo Pharmacies Ltd.(APL) and their respective shareholders.


    The separate entity is anticipated to focus on building a multi-year growth platform for the stand-alone pharmacies business to get to a medium-term target of over 5,000 pharmacy outlets over 5 years with a goal of Rs 10,000 crore in revenues and 30% combined ROCE for the Stand-alone pharmacy business in the next 5 years.


    Once the scheme comes into effect, APL will pay a lump sum amount of Rs. 527.8 crore to Apollo Hospitals in cash.


    Presently, Apollo hospitals hold 100% equity share capital of Apollo Medicals Private Limited ('AMPL') which in turn holds 100% of equity share capital in APL, with Shobana Kamineni the common director for both the entities.


    However, after the implementation of the scheme, Apollo Hospital would be the exclusive supplier for APL under a long term supply agreement and further would also enter into a brand licensing agreement with Apollo Pharmacies to licence the "Apollo Pharmacy" brand to the front end stores and online pharmacy operations, to further augment and strengthen the brand, with these arrangements.


    "The proposed reorganisation would not have a material impact on the financials of AHEL as the backend business related to the stand-alone pharmacies which represent around 85% of the business economics will continue to be held by AHEL," Apollo Hospitals said.


    Apollo Hospitals will utilize the proceeds of divestment towards growth and enhancement of other existing businesses and enhance strategic flexibility to build a viable platform solely focusing on each of the businesses.


    Apollo Pharmacy today has grown from 170 outlets in FY05 to 3,428 outlets as of March 31, 2019, in 400 cities/ towns spread over 20 states and 4 Union territories and is currently serving about 300,000 customers daily through dedicated employee strength of about 21,000 plus.


    Organised pharmacy retail accounts for less than 5% of India's USD 15 billion domestic pharmaceutical market which is estimated to grow 10-12% CAGR over the next decade, driven predominantly by volume growth.


    "The key growth drivers for the domestic pharmaceutical industry include increasing disposable incomes, demand for quality products, higher incidence of chronic diseases, growing awareness of diagnostics and preventive care, and greater accessibility through generics. Organised pharmacy retail is expected to grow at a much faster rate within this," Apollo Hospitals added.


    Also Read: Apollo Pharmacy misappropriation case: CBI carries out searches in BEL hospital

    APLApolloApollo GroupApollo HospitalApollo Pharmacyapollo shareholdersepharmacyNational Company Law TribunalNCLTOnline PharmacyPharmaciespharmacy

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok